DefinitionThis section has been translated automatically.
Antiemetic, dopamine antagonist.
IndicationThis section has been translated automatically.
Prophylactically for cytostatic-induced vomiting, radiation damage or post-operatively.
You might also be interested in
Limited indicationThis section has been translated automatically.
Pregnancy, renal insufficiency.
Dosage and method of useThis section has been translated automatically.
For cytostatic drug therapy 150 mg p.o. before and 150 mg after cytostasis, 3 times 50 mg p.o. the following day. Alternatively 100 mg i.v. before and 100 mg i.v. or i.m. after cytostatic drug application.
Undesirable effectsThis section has been translated automatically.
CNS disorders, dizziness, RR decline, diarrhea, dry mouth, amenorrhea.
InteractionsThis section has been translated automatically.
Table 1.
ContraindicationThis section has been translated automatically.
Children < 14 years, pheochromocytoma, late dyskinesia, prolactinoma.
PreparationsThis section has been translated automatically.
Vergentan
TablesThis section has been translated automatically.
Key interactions of alizapride
Alimemazine |
extrapyramidal symptoms ↑ |
Anticholinergics |
mutual effect ↓ |
Alcohol |
central attenuation |
Chlorphenethazine |
extrapyramidal symptoms ↑ |
Lisurid |
Lisuride effect ↓ |
Mequitazine |
extrapyramidal symptoms ↑ |
Neuroleptics |
extrapyramidal symptoms ↑, avoid combination |
Scopolamine |
Scopolamine effect ↓ |
CNS damping agent |
central damping ↑ |
Prof. Dr. med. Peter Altmeyer